Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipramine as adjunct to antimuscarinic therapy for overactive bladder (randomized double-blind placebo-controlled crossover)
2008-000893-19Phase 4Completed
- Sponsor
- Whittington Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of imipramine in overactive bladder (OAB) (2 arms), sponsored by Whittington Hospital. Started Jun 2008; status: completed.
02
Drugs
imipramine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2008-000893-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000893-19.